ProfileGDS5678 / 1455392_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 8% 9% 9% 8% 9% 8% 8% 9% 9% 10% 9% 8% 9% 9% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.225778
GSM967853U87-EV human glioblastoma xenograft - Control 22.208399
GSM967854U87-EV human glioblastoma xenograft - Control 32.210199
GSM967855U87-EV human glioblastoma xenograft - Control 42.144718
GSM967856U87-EV human glioblastoma xenograft - Control 52.190059
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.233188
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.217918
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.187819
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.183159
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.230810
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.19649
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.163728
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.206589
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.198029